Global Hereditary Cancer Testing Market Insights, Forecast To 2028

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hereditary Cancer Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 RNA Testing
1.2.3 DNA Testing
1.3 Market by Application
1.3.1 Global Hereditary Cancer Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other Cancers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hereditary Cancer Testing Market Perspective (2017-2028)
2.2 Hereditary Cancer Testing Growth Trends by Region
2.2.1 Hereditary Cancer Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Hereditary Cancer Testing Historic Market Size by Region (2017-2022)
2.2.3 Hereditary Cancer Testing Forecasted Market Size by Region (2023-2028)
2.3 Hereditary Cancer Testing Market Dynamics
2.3.1 Hereditary Cancer Testing Industry Trends
2.3.2 Hereditary Cancer Testing Market Drivers
2.3.3 Hereditary Cancer Testing Market Challenges
2.3.4 Hereditary Cancer Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hereditary Cancer Testing Players by Revenue
3.1.1 Global Top Hereditary Cancer Testing Players by Revenue (2017-2022)
3.1.2 Global Hereditary Cancer Testing Revenue Market Share by Players (2017-2022)
3.2 Global Hereditary Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hereditary Cancer Testing Revenue
3.4 Global Hereditary Cancer Testing Market Concentration Ratio
3.4.1 Global Hereditary Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hereditary Cancer Testing Revenue in 2021
3.5 Hereditary Cancer Testing Key Players Head office and Area Served
3.6 Key Players Hereditary Cancer Testing Product Solution and Service
3.7 Date of Enter into Hereditary Cancer Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hereditary Cancer Testing Breakdown Data by Type
4.1 Global Hereditary Cancer Testing Historic Market Size by Type (2017-2022)
4.2 Global Hereditary Cancer Testing Forecasted Market Size by Type (2023-2028)
5 Hereditary Cancer Testing Breakdown Data by Application
5.1 Global Hereditary Cancer Testing Historic Market Size by Application (2017-2022)
5.2 Global Hereditary Cancer Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Hereditary Cancer Testing Market Size (2017-2028)
6.2 North America Hereditary Cancer Testing Market Size by Type
6.2.1 North America Hereditary Cancer Testing Market Size by Type (2017-2022)
6.2.2 North America Hereditary Cancer Testing Market Size by Type (2023-2028)
6.2.3 North America Hereditary Cancer Testing Market Share by Type (2017-2028)
6.3 North America Hereditary Cancer Testing Market Size by Application
6.3.1 North America Hereditary Cancer Testing Market Size by Application (2017-2022)
6.3.2 North America Hereditary Cancer Testing Market Size by Application (2023-2028)
6.3.3 North America Hereditary Cancer Testing Market Share by Application (2017-2028)
6.4 North America Hereditary Cancer Testing Market Size by Country
6.4.1 North America Hereditary Cancer Testing Market Size by Country (2017-2022)
6.4.2 North America Hereditary Cancer Testing Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Hereditary Cancer Testing Market Size (2017-2028)
7.2 Europe Hereditary Cancer Testing Market Size by Type
7.2.1 Europe Hereditary Cancer Testing Market Size by Type (2017-2022)
7.2.2 Europe Hereditary Cancer Testing Market Size by Type (2023-2028)
7.2.3 Europe Hereditary Cancer Testing Market Share by Type (2017-2028)
7.3 Europe Hereditary Cancer Testing Market Size by Application
7.3.1 Europe Hereditary Cancer Testing Market Size by Application (2017-2022)
7.3.2 Europe Hereditary Cancer Testing Market Size by Application (2023-2028)
7.3.3 Europe Hereditary Cancer Testing Market Share by Application (2017-2028)
7.4 Europe Hereditary Cancer Testing Market Size by Country
7.4.1 Europe Hereditary Cancer Testing Market Size by Country (2017-2022)
7.4.2 Europe Hereditary Cancer Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hereditary Cancer Testing Market Size (2017-2028)
8.2 Asia-Pacific Hereditary Cancer Testing Market Size by Type
8.2.1 Asia-Pacific Hereditary Cancer Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Hereditary Cancer Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Hereditary Cancer Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Hereditary Cancer Testing Market Size by Application
8.3.1 Asia-Pacific Hereditary Cancer Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Hereditary Cancer Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Hereditary Cancer Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Hereditary Cancer Testing Market Size by Region
8.4.1 Asia-Pacific Hereditary Cancer Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Hereditary Cancer Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hereditary Cancer Testing Market Size (2017-2028)
9.2 Latin America Hereditary Cancer Testing Market Size by Type
9.2.1 Latin America Hereditary Cancer Testing Market Size by Type (2017-2022)
9.2.2 Latin America Hereditary Cancer Testing Market Size by Type (2023-2028)
9.2.3 Latin America Hereditary Cancer Testing Market Share by Type (2017-2028)
9.3 Latin America Hereditary Cancer Testing Market Size by Application
9.3.1 Latin America Hereditary Cancer Testing Market Size by Application (2017-2022)
9.3.2 Latin America Hereditary Cancer Testing Market Size by Application (2023-2028)
9.3.3 Latin America Hereditary Cancer Testing Market Share by Application (2017-2028)
9.4 Latin America Hereditary Cancer Testing Market Size by Country
9.4.1 Latin America Hereditary Cancer Testing Market Size by Country (2017-2022)
9.4.2 Latin America Hereditary Cancer Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hereditary Cancer Testing Market Size (2017-2028)
10.2 Middle East & Africa Hereditary Cancer Testing Market Size by Type
10.2.1 Middle East & Africa Hereditary Cancer Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Hereditary Cancer Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Hereditary Cancer Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Hereditary Cancer Testing Market Size by Application
10.3.1 Middle East & Africa Hereditary Cancer Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Hereditary Cancer Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Hereditary Cancer Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Hereditary Cancer Testing Market Size by Country
10.4.1 Middle East & Africa Hereditary Cancer Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Hereditary Cancer Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Ambry Genetics (Konica Minota)
11.1.1 Ambry Genetics (Konica Minota) Company Details
11.1.2 Ambry Genetics (Konica Minota) Business Overview
11.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Introduction
11.1.4 Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2017-2022)
11.1.5 Ambry Genetics (Konica Minota) Recent Developments
11.2 Asper Biogene
11.2.1 Asper Biogene Company Details
11.2.2 Asper Biogene Business Overview
11.2.3 Asper Biogene Hereditary Cancer Testing Introduction
11.2.4 Asper Biogene Revenue in Hereditary Cancer Testing Business (2017-2022)
11.2.5 Asper Biogene Recent Developments
11.3 Natera
11.3.1 Natera Company Details
11.3.2 Natera Business Overview
11.3.3 Natera Hereditary Cancer Testing Introduction
11.3.4 Natera Revenue in Hereditary Cancer Testing Business (2017-2022)
11.3.5 Natera Recent Developments
11.4 Caris Life Sciences
11.4.1 Caris Life Sciences Company Details
11.4.2 Caris Life Sciences Business Overview
11.4.3 Caris Life Sciences Hereditary Cancer Testing Introduction
11.4.4 Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022)
11.4.5 Caris Life Sciences Recent Developments
11.5 BioReference Laboratories (GeneDx)
11.5.1 BioReference Laboratories (GeneDx) Company Details
11.5.2 BioReference Laboratories (GeneDx) Business Overview
11.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Introduction
11.5.4 BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2017-2022)
11.5.5 BioReference Laboratories (GeneDx) Recent Developments
11.6 LabSolutions
11.6.1 LabSolutions Company Details
11.6.2 LabSolutions Business Overview
11.6.3 LabSolutions Hereditary Cancer Testing Introduction
11.6.4 LabSolutions Revenue in Hereditary Cancer Testing Business (2017-2022)
11.6.5 LabSolutions Recent Developments
11.7 Progenity，Inc
11.7.1 Progenity，Inc Company Details
11.7.2 Progenity，Inc Business Overview
11.7.3 Progenity，Inc Hereditary Cancer Testing Introduction
11.7.4 Progenity，Inc Revenue in Hereditary Cancer Testing Business (2017-2022)
11.7.5 Progenity，Inc Recent Developments
11.8 ARUP Laboratories
11.8.1 ARUP Laboratories Company Details
11.8.2 ARUP Laboratories Business Overview
11.8.3 ARUP Laboratories Hereditary Cancer Testing Introduction
11.8.4 ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2017-2022)
11.8.5 ARUP Laboratories Recent Developments
11.9 Myriad
11.9.1 Myriad Company Details
11.9.2 Myriad Business Overview
11.9.3 Myriad Hereditary Cancer Testing Introduction
11.9.4 Myriad Revenue in Hereditary Cancer Testing Business (2017-2022)
11.9.5 Myriad Recent Developments
11.10 NeoGenomics
11.10.1 NeoGenomics Company Details
11.10.2 NeoGenomics Business Overview
11.10.3 NeoGenomics Hereditary Cancer Testing Introduction
11.10.4 NeoGenomics Revenue in Hereditary Cancer Testing Business (2017-2022)
11.10.5 NeoGenomics Recent Developments
11.11 Blueprint Genetics
11.11.1 Blueprint Genetics Company Details
11.11.2 Blueprint Genetics Business Overview
11.11.3 Blueprint Genetics Hereditary Cancer Testing Introduction
11.11.4 Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2017-2022)
11.11.5 Blueprint Genetics Recent Developments
11.12 CellMax Life
11.12.1 CellMax Life Company Details
11.12.2 CellMax Life Business Overview
11.12.3 CellMax Life Hereditary Cancer Testing Introduction
11.12.4 CellMax Life Revenue in Hereditary Cancer Testing Business (2017-2022)
11.12.5 CellMax Life Recent Developments
11.13 Fulgent Genetics
11.13.1 Fulgent Genetics Company Details
11.13.2 Fulgent Genetics Business Overview
11.13.3 Fulgent Genetics Hereditary Cancer Testing Introduction
11.13.4 Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2017-2022)
11.13.5 Fulgent Genetics Recent Developments
11.14 Strand Life Sciences
11.14.1 Strand Life Sciences Company Details
11.14.2 Strand Life Sciences Business Overview
11.14.3 Strand Life Sciences Hereditary Cancer Testing Introduction
11.14.4 Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022)
11.14.5 Strand Life Sciences Recent Developments
11.15 Myogenes
11.15.1 Myogenes Company Details
11.15.2 Myogenes Business Overview
11.15.3 Myogenes Hereditary Cancer Testing Introduction
11.15.4 Myogenes Revenue in Hereditary Cancer Testing Business (2017-2022)
11.15.5 Myogenes Recent Developments
11.16 LabCorp
11.16.1 LabCorp Company Details
11.16.2 LabCorp Business Overview
11.16.3 LabCorp Hereditary Cancer Testing Introduction
11.16.4 LabCorp Revenue in Hereditary Cancer Testing Business (2017-2022)
11.16.5 LabCorp Recent Developments
11.17 Quest Diagnostics
11.17.1 Quest Diagnostics Company Details
11.17.2 Quest Diagnostics Business Overview
11.17.3 Quest Diagnostics Hereditary Cancer Testing Introduction
11.17.4 Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2017-2022)
11.17.5 Quest Diagnostics Recent Developments
11.18 Pathway Genomics
11.18.1 Pathway Genomics Company Details
11.18.2 Pathway Genomics Business Overview
11.18.3 Pathway Genomics Hereditary Cancer Testing Introduction
11.18.4 Pathway Genomics Revenue in Hereditary Cancer Testing Business (2017-2022)
11.18.5 Pathway Genomics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Hereditary Cancer Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of RNA Testing
Table 3. Key Players of DNA Testing
Table 4. Global Hereditary Cancer Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Hereditary Cancer Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Hereditary Cancer Testing Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Hereditary Cancer Testing Market Share by Region (2017-2022)
Table 8. Global Hereditary Cancer Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Hereditary Cancer Testing Market Share by Region (2023-2028)
Table 10. Hereditary Cancer Testing Market Trends
Table 11. Hereditary Cancer Testing Market Drivers
Table 12. Hereditary Cancer Testing Market Challenges
Table 13. Hereditary Cancer Testing Market Restraints
Table 14. Global Hereditary Cancer Testing Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Hereditary Cancer Testing Revenue Share by Players (2017-2022)
Table 16. Global Top Hereditary Cancer Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Cancer Testing as of 2021)
Table 17. Ranking of Global Top Hereditary Cancer Testing Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Hereditary Cancer Testing Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hereditary Cancer Testing Product Solution and Service
Table 21. Date of Enter into Hereditary Cancer Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hereditary Cancer Testing Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Hereditary Cancer Testing Revenue Market Share by Type (2017-2022)
Table 25. Global Hereditary Cancer Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Hereditary Cancer Testing Revenue Market Share by Type (2023-2028)
Table 27. Global Hereditary Cancer Testing Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Hereditary Cancer Testing Revenue Share by Application (2017-2022)
Table 29. Global Hereditary Cancer Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Hereditary Cancer Testing Revenue Share by Application (2023-2028)
Table 31. North America Hereditary Cancer Testing Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Hereditary Cancer Testing Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Hereditary Cancer Testing Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Hereditary Cancer Testing Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Hereditary Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Hereditary Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Hereditary Cancer Testing Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Hereditary Cancer Testing Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Hereditary Cancer Testing Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Hereditary Cancer Testing Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Hereditary Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Hereditary Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Hereditary Cancer Testing Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Hereditary Cancer Testing Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Hereditary Cancer Testing Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Hereditary Cancer Testing Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Hereditary Cancer Testing Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Hereditary Cancer Testing Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Hereditary Cancer Testing Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Hereditary Cancer Testing Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Hereditary Cancer Testing Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Hereditary Cancer Testing Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Hereditary Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Hereditary Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Hereditary Cancer Testing Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Hereditary Cancer Testing Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Hereditary Cancer Testing Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Hereditary Cancer Testing Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Hereditary Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Hereditary Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
Table 61. Ambry Genetics (Konica Minota) Company Details
Table 62. Ambry Genetics (Konica Minota) Business Overview
Table 63. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Product
Table 64. Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
Table 65. Ambry Genetics (Konica Minota) Recent Developments
Table 66. Asper Biogene Company Details
Table 67. Asper Biogene Business Overview
Table 68. Asper Biogene Hereditary Cancer Testing Product
Table 69. Asper Biogene Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
Table 70. Asper Biogene Recent Developments
Table 71. Natera Company Details
Table 72. Natera Business Overview
Table 73. Natera Hereditary Cancer Testing Product
Table 74. Natera Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
Table 75. Natera Recent Developments
Table 76. Caris Life Sciences Company Details
Table 77. Caris Life Sciences Business Overview
Table 78. Caris Life Sciences Hereditary Cancer Testing Product
Table 79. Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
Table 80. Caris Life Sciences Recent Developments
Table 81. BioReference Laboratories (GeneDx) Company Details
Table 82. BioReference Laboratories (GeneDx) Business Overview
Table 83. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Product
Table 84. BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
Table 85. BioReference Laboratories (GeneDx) Recent Developments
Table 86. LabSolutions Company Details
Table 87. LabSolutions Business Overview
Table 88. LabSolutions Hereditary Cancer Testing Product
Table 89. LabSolutions Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
Table 90. LabSolutions Recent Developments
Table 91. Progenity，Inc Company Details
Table 92. Progenity，Inc Business Overview
Table 93. Progenity，Inc Hereditary Cancer Testing Product
Table 94. Progenity，Inc Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
Table 95. Progenity，Inc Recent Developments
Table 96. ARUP Laboratories Company Details
Table 97. ARUP Laboratories Business Overview
Table 98. ARUP Laboratories Hereditary Cancer Testing Product
Table 99. ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
Table 100. ARUP Laboratories Recent Developments
Table 101. Myriad Company Details
Table 102. Myriad Business Overview
Table 103. Myriad Hereditary Cancer Testing Product
Table 104. Myriad Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
Table 105. Myriad Recent Developments
Table 106. NeoGenomics Company Details
Table 107. NeoGenomics Business Overview
Table 108. NeoGenomics Hereditary Cancer Testing Product
Table 109. NeoGenomics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
Table 110. NeoGenomics Recent Developments
Table 111. Blueprint Genetics Company Details
Table 112. Blueprint Genetics Business Overview
Table 113. Blueprint Genetics Hereditary Cancer Testing Product
Table 114. Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
Table 115. Blueprint Genetics Recent Developments
Table 116. CellMax Life Company Details
Table 117. CellMax Life Business Overview
Table 118. CellMax Life Hereditary Cancer Testing Product
Table 119. CellMax Life Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
Table 120. CellMax Life Recent Developments
Table 121. Fulgent Genetics Company Details
Table 122. Fulgent Genetics Business Overview
Table 123. Fulgent Genetics Hereditary Cancer Testing Product
Table 124. Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
Table 125. Fulgent Genetics Recent Developments
Table 126. Strand Life Sciences Company Details
Table 127. Strand Life Sciences Business Overview
Table 128. Strand Life Sciences Hereditary Cancer Testing Product
Table 129. Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
Table 130. Strand Life Sciences Recent Developments
Table 131. Myogenes Company Details
Table 132. Myogenes Business Overview
Table 133. Myogenes Hereditary Cancer Testing Product
Table 134. Myogenes Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
Table 135. Myogenes Recent Developments
Table 136. LabCorp Company Details
Table 137. LabCorp Business Overview
Table 138. LabCorp Hereditary Cancer Testing Product
Table 139. LabCorp Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
Table 140. LabCorp Recent Developments
Table 141. Quest Diagnostics Company Details
Table 142. Quest Diagnostics Business Overview
Table 143. Quest Diagnostics Hereditary Cancer Testing Product
Table 144. Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
Table 145. Quest Diagnostics Recent Developments
Table 146. Pathway Genomics Company Details
Table 147. Pathway Genomics Business Overview
Table 148. Pathway Genomics Hereditary Cancer Testing Product
Table 149. Pathway Genomics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
Table 150. Pathway Genomics Recent Developments
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hereditary Cancer Testing Market Share by Type: 2021 VS 2028
Figure 2. RNA Testing Features
Figure 3. DNA Testing Features
Figure 4. Global Hereditary Cancer Testing Market Share by Application: 2021 VS 2028
Figure 5. Breast Cancer Case Studies
Figure 6. Gastrointestinal Cancer Case Studies
Figure 7. Prostate Cancer Case Studies
Figure 8. Respiratory/Lung Cancer Case Studies
Figure 9. Other Cancers Case Studies
Figure 10. Hereditary Cancer Testing Report Years Considered
Figure 11. Global Hereditary Cancer Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Hereditary Cancer Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Hereditary Cancer Testing Market Share by Region: 2021 VS 2028
Figure 14. Global Hereditary Cancer Testing Market Share by Players in 2021
Figure 15. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Cancer Testing as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Hereditary Cancer Testing Revenue in 2021
Figure 17. North America Hereditary Cancer Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Hereditary Cancer Testing Market Size Market Share by Type (2017-2028)
Figure 19. North America Hereditary Cancer Testing Market Size Market Share by Application (2017-2028)
Figure 20. North America Hereditary Cancer Testing Market Size Share by Country (2017-2028)
Figure 21. United States Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Hereditary Cancer Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Hereditary Cancer Testing Market Size Market Share by Type (2017-2028)
Figure 25. Europe Hereditary Cancer Testing Market Size Market Share by Application (2017-2028)
Figure 26. Europe Hereditary Cancer Testing Market Size Share by Country (2017-2028)
Figure 27. Germany Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Hereditary Cancer Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Hereditary Cancer Testing Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Hereditary Cancer Testing Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Hereditary Cancer Testing Market Size Share by Region (2017-2028)
Figure 37. China Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Hereditary Cancer Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Hereditary Cancer Testing Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Hereditary Cancer Testing Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Hereditary Cancer Testing Market Size Share by Country (2017-2028)
Figure 47. Mexico Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Hereditary Cancer Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Hereditary Cancer Testing Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Hereditary Cancer Testing Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Hereditary Cancer Testing Market Size Share by Country (2017-2028)
Figure 53. Turkey Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Ambry Genetics (Konica Minota) Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
Figure 57. Asper Biogene Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
Figure 58. Natera Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
Figure 59. Caris Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
Figure 60. BioReference Laboratories (GeneDx) Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
Figure 61. LabSolutions Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
Figure 62. Progenity，Inc Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
Figure 63. ARUP Laboratories Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
Figure 64. Myriad Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
Figure 65. NeoGenomics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
Figure 66. Blueprint Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
Figure 67. CellMax Life Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
Figure 68. Fulgent Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
Figure 69. Strand Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
Figure 70. Myogenes Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
Figure 71. LabCorp Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
Figure 72. Quest Diagnostics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
Figure 73. Pathway Genomics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.